Clinical trials: Radiotherapy-induced Nausea and Vomiting (RINV)
Radiotherapy-induced Nausea and Vomiting (RINV)
Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
The purpose of this study is to explore the dose response of SyB D-0701 for preventing nausea and emesis associated with radiotherapy (fractionated/localized irradiation) in cancer patients scheduled to receive radiotherapy…
- Trial name
- NCT01700140
- Testing
- SyB D-0701
- Where
- 21 sites in Japan
- Volunteers
- 189 people
- Sponsor
- SymBio Pharmaceuticals